SLUG: A new target of lymphoid enhancer factor-1 in human osteoblasts

BMC Molecular Biology

Volumn 11, Issue , 2010, Pages

  Lambertini, Elisabetta ^a   Franceschetti, Tiziana ^a,b   Torreggiani, Elena ^a   Penolazzi, Letizia ^a   Pastore, Antonio ^a   Pelucchi, Stefano ^a   Gambari, Roberto ^a   Piva, Roberta ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; BETA CATENIN; LYMPHOID ENHANCER FACTOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR 7; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; WNT PROTEIN; PROTEIN KINASE INHIBITOR; RUNX2 PROTEIN, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS;

ARTICLE; BONE MATRIX; BONE TISSUE; CELL CULTURE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EXPRESSION VECTOR; GENETIC REGULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MESENCHYME CELL; OSTEOBLAST; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL; UMBILICAL CORD; GENETICS; METABOLISM;

GASTROPODA;

BETA CATENIN; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; OSTEOBLASTS; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 77949503814     PISSN: None     EISSN: 14712199     Source Type: Journal    
DOI: 10.1186/1471-2199-11-13     Document Type: Article

References (50)

1. Barker N. The canonical Wnt/beta-catenin signalling pathway. Methods Mol Biol 2008, 468:5-15. full_text, 19099242.
2. Westendorf JJ, Kahler RA, Schroeder TM. Wnt signaling in osteoblasts and bone diseases. Gene 2004, 341:19-39. 10.1016/j.gene.2004.06.044, 15474285.
3. Leucht P, Minears S, Ten Berge D, Nusse R, Helms JA. Translating insights from development into regenerative medicine: the function of Wnts in bone biology. Semin Cell Dev Biol 2008, 19(5):434-443. 10.1016/j.semcdb.2008.09.002, 18824114.
4. Day TF, Guo X, Garrett-Beal L, Yang Y. Wnt/beta-catenin signalling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 2005, 8(5):739-50. 10.1016/j.devcel.2005.03.016, 15866164.
5. Matsuzaki E, Takahashi-Yanaga F, Miwa Y, Hirata M, Watanabe Y, Sato N, Morimoto S, Hirofuji T, Maeda K, Sasaguri T. Differentiation-inducing factor-1 alters canonical Wnt signalling and suppresses alkaline phosphatase expression in osteoblast-like cell lines. J Bone Miner Res 2006, 21(8):1307-16. 10.1359/jbmr.060512, 16869729.
6. Hoeppner LH, Secreto F, Jensen ED, Li X, Kahler RA, Westendorf JJ. RUNX2 and bone morphogenic protein 2 regulate the expression of an alternative Lef1 transcript during osteoblast maturation. J Cell Physiol 2009, 221(2):480-89. 10.1002/jcp.21879, 19650108.
7. Noh T, Gabet Y, Cogan J, Shi Y, Tank A, Sasaki T, Criswell B, Dixon A, Lee C, Tam J, Kohler T, Segev E, Kockeritz L, Woodgett J, Müller R, Chai Y, Smith E, Bab I, Frenkel B. Lef1 haploinsufficient mice display a low turnover and low bone mass phenotype in a gender- and age-specific manner. PLoS One 2009, 4(5):e5438. 10.1371/journal.pone.0005438, 2673053, 19412553.
8. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002, 3(3):155-66. 10.1038/nrm757, 11994736.
9. Hemavathy K, Ashraf SI, Ip YT. Snail/SLUG family of repressors: slowly going into the fast lane of development and cancer. Gene 2000, 257(1):1-12. 10.1016/S0378-1119(00)00371-1, 11054563.
10. De Craene B, van Roy F, Berx G. Unraveling signalling cascades for the Snail family of transcription factors. Cell Signal 2005, 17(5):17535-47.
11. Hemavathy K, Guru SC, Harris J, Chen JD, Ip YT. Human SLUG is a repressor that localizes to sites of active transcription. Mol Cell Biol 2000, 20(14):5087-95. 10.1128/MCB.20.14.5087-5095.2000, 85958, 10866665.
12. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, Mareel M, Huylebroeck D, van Roy F. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001, 7(6):1267-78. 10.1016/S1097-2765(01)00260-X, 11430829.
13. Przybylo JA, Radisky DC. Matrix metalloproteinase-induced epithelial-mesenchymal transition: Tumor progression at Snail's pace. Int J Biochem Cell Biol 2007, 39(6):1082-88. 10.1016/j.biocel.2007.03.002, 17416542.
14. Perez-Mancera PA, Gonzals-Herrero I, Perez-Caro M, Gutierrez-Cianca N, Flores T, Gutierrez-Adan A, Pintado B, Sánchez-Martín M, Sánchez-García I. SLUG in cancer development. Oncogene 2005, 24(19):3073-82. 10.1038/sj.onc.1208505, 15735690.
15. Castro Alves C, Rosivatz E, Schott C, Hollweck R, Becker I, Sarbia M, Carneiro F, Becker KF. SLUG is overexpressed in gastic carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin. J Pathol 2007, 211(5):507-15. 10.1002/path.2138, 17299729.
16. Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002, 62(6):1613-18.
17. Storci G, Sansone P, Trere D, Tavolari S, Taffurelli M, Ceccarelli C, Guarnieri T, Paterini P, Pariali M, Montanaro L, Santini D, Chieco P, Bonafé M. The basal-like breast carcinoma phenotype is regulated by SLUG gene expression. J Pathol 2008, 214(1):25-37. 10.1002/path.2254, 17973239.
18. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: Implications in development and cancer. Development 2005, 132(14):3151-61. 10.1242/dev.01907, 15983400.
19. Pérez-Losada J, Sánchez-Martín M, Rodríguez-García A, Sánchez ML, Orfao A, Flores T, Sánchez-García I. Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathway. Blood 2002, 100(4):1274-86.
20. Pérez-Mancera PA, Bermejo-Rodríguez C, González-Herrero I, Herranz M, Flores T, Jiménez R, Sánchez-García I. Adipose tissue mass is modulated by SLUG (SNAI2). Hum Mol Genet 2007, 16(23):2972-86. 10.1093/hmg/ddm278, 17905753.
21. Carl TF, Dufton C, Hanken J, Klymkowsky MW. Inibition of neural crest migration in Xenopus using antisense SLUG RNA. Dev Biol 1999, 213(1):101-15. 10.1006/dbio.1999.9320, 10452849.
22. LaBonne C, Bronner-Fraser M. Snail-related transcriptional repressors are required in Xenopus for both the induction of the neural crest and its susequent migration. Dev Biol 2000, 221(1):195-205. 10.1006/dbio.2000.9609, 10772801.
23. Cohen ME, Yin M, Paznekas WA, Schertzer M, Wood S, Jabs EW. Human SLUG gene organization, expression, and chromosome map location on 8q. Genomics 1998, 51(3):468-71. 10.1006/geno.1998.5367, 9721220.
24. Savagner P, Kusewitt DF, Carver EA, Magnino F, Choi C, Gridley T, Hudson LG. Developmental transcription factor SLUG is required for effective re-epithelization by adult keratinocytes. J Cell Physiol 2005, 202(3):858-66. 10.1002/jcp.20188, 15389643.
25. Yamamoto Y, Banas A, Murata S, Ishikawa M, Lim CR, Teratani T, Hatada I, Matsubara K, Kato T, Ochiya T. A comparative analysis of the transcriptome and signal pathway in hepatic differentiation of human adipose mesenchymal stem cells. FEBS 2008, 275(6):1260-73.
26. Basch ML, Bronner-Fraser M, Garcia-Castro M. Specification of the neural crest occurs during gastrulation and requires Pax7. Nature 2006, 441(7090):218-22. 10.1038/nature04684, 16688176.
27. Le Douarin NM, Dupin E, Ziller C. Genetic and epigenetic control in neural crest development. Curr Opin Genet Dev 1994, 4:685-95. 10.1016/0959-437X(94)90135-P, 7849508.
28. Sarnat HB, Flores-Sarnat L. Embriology of the neural crest: its inductive role in the neurocutaneous syndromes. J Chil Neurol 2005, 20(8):637-43.
29. Sakai D, Suzuki T, Osumi N, Wakamatsu Y. Cooperative action of Sox-9, Snail2 and PKA signaling in early neural crest development. Development 2006, 133(7):1323-33. 10.1242/dev.02297, 16510505.
30. Lambertini E, Lisignoli G, Torreggiani E, Manferdini C, Gabusi E, Franceschetti T, Penolazzi L, Gambari R, Facchini A, Piva R. SLUG gene expression supports human osteoblast maturation. Cell Mol Life Sciences 2009, 66(22):3641-53.
31. Guo Y, Zi X, Koontz Z, Kim A, Xie J, Gorlick R, Holcombe RF, Hoang BH. Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma SaOS-2 cells. J Orthop Res 2007, 25(7):964-71. 10.1002/jor.20356, 17318900.
32. Sakai D, Tanaka Y, Endo Y, Osumi N, Okamoto H, Wakamatsu Y. Regulation of SLUG transcription in embryonic ectoderm by beta-catenin-Lef/Tcf and BMP-Smad signalling. Dev Growth Differ 2005, 47(7):471-82. 10.1111/j.1440-169X.2005.00821.x, 16179074.
33. Vallin J, Thuret R, Giacomello E, Faraldo MM, Thiery JP, Broders F. Cloning and characterization of three Xenopus SLUG promoters reveal direct regulation by Lef/beta-catenin signalling. J Biol Chem 2001, 276(32):30350-8. 10.1074/jbc.M103167200, 11402039.
34. Saegusa M, Hashimura M, Kuwata T, Okayasu I. Requirement of the Akt/β-catenin pathway for uterine carcinosarcoma genesis, modulating E-cadherin expression through the transactivation of SLUG. Am J Pathol 2009, 174(6):2107-15. 10.2353/ajpath.2009.081018, 19389926.
35. Hong CF, Chou YT, Lin YS, Wu CW. MAD2B, a novel TCF4-binding protein, modulates TCF4-mediated epithelial-mesenchymal transdifferentiation. J Biol Chem 2009, 284(29):19613-22. 10.1074/jbc.M109.005017, 19443654.
36. Penolazzi L, Tavanti E, Vecchiatini R, Lambertini E, Vesce F, Gambari R, Mazzitelli S, Mancuso F, Luca G, Nastruzzi C, Piva R. Encapsulation of mesenchymal stem cells from Wharton's jelly in alginate microbeads. Tissue Eng Part C Methods 2010, 16(1):141-155. 19402785, 10.1089/ten.tec.2008.0582.
37. Marie PJ. Transcription factors controlling osteoblastogenesis. Arch Biochem Biophys 2008, 473(2):98-105. 10.1016/j.abb.2008.02.030, 18331818.
38. de Frutos CA, Dacquin R, Vega S, Jurdic P, Machuca-Gayet I, Nieto MA. Snail1 controls bone mass by regulating Runx2 and VDR expression during osteoblast differentiation. EMBO J 2009, 28(6):686-96. 10.1038/emboj.2009.23, 2647771,2647771, 19197242.
39. Katoh M, Katoh M. Identification and characterization of human SNAIL3 (SNAI3) gene in silico. Int J Mol Med 2003, 11(3):383-8.
40. Cohen P, Frame S. The renaissance of GSK3. Nat Rev Mol Cell Biol 2001, 2(10):769-76. 10.1038/35096075, 11584304.
41. Patel S, Doble B, Woodgett JR. Glycogen synthase kinase-3 in insulin and Wnt signalling: a double-edged word?. Biochem Soc Trans 2004, 32(Pt 5):803-8.
42. Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, SLUG, and MAPK. J Cell Biol 2003, 163(4):847-57. 10.1083/jcb.200308162, 2173691, 14623871.
43. Nusse R. WNT targets. Repression and activation. Trends Genet 1999, 15(1):1-3. 10.1016/S0168-9525(98)01634-5, 10087922.
44. Case N, Ma M, Sen B, Xie Z, Gross TS, Rubin J. Beta-catenin levels influence rapid mechanical responses in osteoblasts. J Biol Chem 2008, 283(43):29196-205. 10.1074/jbc.M801907200, 2570859, 18723514.
45. Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB. Canonical WNT signalling promotes osteogenesis by directly stimulating RUNX2 gene expression. J Biol Chem 2005, 280(39):33132-40. 10.1074/jbc.M500608200, 16043491.
46. Kahler RA, Yingst SM, Hoeppner L, Jensen ED, Krawczak D, Oxford JT, Westendorf JJ. Collagen 11a1 is indirectly activated by lymphocyte enhancer-binding facor 1 (Lef1) and negatively regulates osteoblast maturation. Matrix Biol 2008, 27(4):330-8. 10.1016/j.matbio.2008.01.002, 2431459, 18280717.
47. Inukai T, Inoue A, Kurosawa H, Goi K, Shinjyo T, Ozawa K, Mao M, Inaba T, Look AT. SLUG a ces-1-Related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF Oncoprotein. Mol Cell 1999, 4(3):343-52. 10.1016/S1097-2765(00)80336-6, 10518215.
48. Kousteni S, Almeida M, Han L, Bellido T, Jilka RL, Manolagas SC. Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor. Mol Cell Biol 2007, 27(4):1516-30. 10.1128/MCB.01550-06, 1800724, 17158928.
49. Penolazzi L, Zennaro M, Lambertini E, Tavanti E, Torreggiani E, Gambari R, Piva R. Induction of estrogen receptor alpha expression with decoy oligonucleotide targeted to NFATc1 binding sites in osteoblasts. Mol Pharmacol 2007, 71(6):1457-62. 10.1124/mol.107.034561, 17389747.
50. Lambertini E, Tavanti E, Torreggiani E, Penolazzi L, Gambari R, Piva R. ER alpha and AP-1 interact in vivo with a specific sequence of the F promoter of the human ER alpha gene in osteoblasts. J Cell Physiol 2008, 216(1):101-10. 10.1002/jcp.21379, 18247370.